{"nct_id":"NCT01343043","title":"A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2012-09-27","start_date_type":"ACTUAL","primary_completion_date":"2019-06-18","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}